The standardised tumour mutation burden (TMB) analysis is shown in Figure 3A, where NFE2L2, NOTCH1, SYNE2, FAT3, PAPPA2 and FMN2 showed lower mutation frequencies in the low‐risk corner. This evidence concerns the gene FAT3 and neoplasm.